A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
JF Boggess, PA Gehrig, L Cantrell, A Shafer… - American journal of …, 2008 - Elsevier
OBJECTIVE: The purpose of this study was to compare outcomes in women who underwent
endometrial cancer staging by different surgical techniques. STUDY DESIGN: Three …
endometrial cancer staging by different surgical techniques. STUDY DESIGN: Three …
Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
…, C Zhou, A Mendivil, KM Malloy, PA Gehrig… - Gynecologic …, 2010 - Elsevier
OBJECTIVES: Obesity and diabetes are strong risk factors that drive the development of
type I endometrial cancers. Recent epidemiological evidence suggests that metformin may …
type I endometrial cancers. Recent epidemiological evidence suggests that metformin may …
Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document
GJ Gardner, D Reidy-Lagunes, PA Gehrig - Gynecologic oncology, 2011 - Elsevier
Objective Neuroendocrine tumors of the gynecologic tract are rare, and pose a significant
clinical challenge because of the tumor heterogeneity and lack of standardized guidelines for …
clinical challenge because of the tumor heterogeneity and lack of standardized guidelines for …
What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
PA Gehrig, LA Cantrell, A Shafer, LN Abaid… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: Thirty-three percent of US women are either obese or morbidly obese. This is
associated with an increased risk of death from all causes and is also associated with an …
associated with an increased risk of death from all causes and is also associated with an …
A case-control study of robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radical hysterectomy
JF Boggess, PA Gehrig, L Cantrell, A Shafer… - American journal of …, 2008 - Elsevier
OBJECTIVE: The purpose of this study was to compare robotically assisted hysterectomy (RAH)
with open (ORH) type III radical hysterectomy in the treatment of early-stage cervical …
with open (ORH) type III radical hysterectomy in the treatment of early-stage cervical …
Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review
DM Boruta II, PA Gehrig, AN Fader, AB Olawaiye - Gynecologic oncology, 2009 - Elsevier
OBJECTIVE: Uterine papillary serous carcinoma (UPSC) is a clinically and pathologically
distinct subtype of endometrial cancer. Although less common than its endometrioid carcinoma …
distinct subtype of endometrial cancer. Although less common than its endometrioid carcinoma …
Metformin is associated with improved survival in endometrial cancer
…, LJ Havrilesky, AA Secord, DT Moore, PA Gehrig… - Gynecologic …, 2014 - Elsevier
Objective Preclinical evidence suggests that metformin exhibits anti-tumorigenic effects in
endometrial cancer. We sought to investigate the association of metformin on endometrial …
endometrial cancer. We sought to investigate the association of metformin on endometrial …
Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes
A Mendivil, KM Schuler, PA Gehrig - Cancer control, 2009 - journals.sagepub.com
Background Understanding the etiology, presentation, evaluation, and management of
selected non-endometrioid endometrial adenocarcinomas of the uterine corpus is needed to …
selected non-endometrioid endometrial adenocarcinomas of the uterine corpus is needed to …
Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma
…, HE Gibbons, WK Huh, LJ Havrilesky, PA Gehrig… - Cancer, 2009 - Wiley Online Library
BACKGROUND: A study was undertaken to determine recurrence patterns and survival
outcomes of stage I uterine papillary serous carcinoma (UPSC) patients. METHODS: A …
outcomes of stage I uterine papillary serous carcinoma (UPSC) patients. METHODS: A …
Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
…, C Zhou, KM Malloy, L Sun, Y Zhong, PA Gehrig… - Gynecologic …, 2012 - Elsevier
OBJECTIVES: To examine the effects of combination therapy with metformin and paclitaxel
in endometrial cancer cell lines. METHODS: ECC-1 and Ishikawa endometrial cancer cell …
in endometrial cancer cell lines. METHODS: ECC-1 and Ishikawa endometrial cancer cell …